Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
vendredi, novembre 20
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Acadia Healthcare Co Inc
ACHC
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$34.47
-3.12
-8.3%
À la clôture: Nov 19, 4:00 PM EST
$34.47
-3.12
-8.3%
Pré-ouverture: 8:21 AM EST
Get Report
Aperçu
Actualités
Graphiques
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Acadia Healthcare Co Financials
Acadia Healthcare Co (ACHC) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Acadia Healthcare Co Raises FY2026 Adj EPS Guidance from $1.45-$1.60 to $1.70-$1.80 vs $1.55 Est; Raises FY2026 Sales Guidance from $3.400B-$3.450B to $3.440B-$3.460B vs $3.427B Est
Acadia Healthcare Co (NASDAQ:ACHC) raises FY2026 Adj EPS guidance from $1.45-$1.60 to $1.70-$1.80 vs $1.55 analyst estimate. Raises FY2026 sales outlook from $3.400 billion-$3.450 billion to $3.440 billion-$3.460
Benzinga Newsdesk
PRO
Acadia Healthcare Co Q3 Adj. EPS $0.60 Beats $0.46 Estimate, Sales $895.309M Beat $877.879M Estimate
Acadia Healthcare Co (NASDAQ:ACHC) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.46 by 30.43 percent. This is a 16.67 percent decrease over earnings of $0.72 per share
Benzinga Newsdesk
PRO
Acadia Healthcare Co Raises FY2026 Adj EPS Guidance from $1.35-$1.60 to $1.45-$1.60 vs $1.51 Est; Raises FY2026 Sales Guidance from $3.370B-$3.450B to $3.400B-$3.450B vs $3.409B Est
Acadia Healthcare Co (NASDAQ:ACHC) raises FY2026 Adj EPS guidance from $1.35-$1.60 to $1.45-$1.60 vs $1.51 analyst estimate. Raises FY2026 sales outlook from $3.370 billion-$3.450 billion to $3.400 billion-$3.450
Benzinga Newsdesk
PRO
Acadia Healthcare Co Q2 Adj. EPS $0.38 Beats $0.35 Estimate, Sales $865.839M Beat $844.232M Estimate
Benzinga Newsdesk
PRO
Acadia Healthcare Co Raises FY2026 Adj EPS Guidance from $1.30-$1.55 to $1.35-$1.60 vs $1.49 Est; Affirms FY2026 Sales Guidance of $3.370B-$3.450B vs $3.413B Est
Acadia Healthcare Co (NASDAQ:ACHC) raises FY2026 Adj EPS guidance from $1.30-$1.55 to $1.35-$1.60 vs $1.49 analyst estimate. Affirms FY2026 sales outlook from $3.370 billion-$3.450 billion to $3.370 billion-$3.450
Benzinga Newsdesk
PRO
Acadia Healthcare Co Q1 Adj. EPS $0.37 Beats $0.27 Estimate, Sales $828.808M Beat $822.924M Estimate
Acadia Healthcare Co (NASDAQ:ACHC) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.27 by 37.04 percent. This is a 7.5 percent decrease over earnings of $0.40 per share from
Benzinga Newsdesk